Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Income from Continuing Operations (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Income from Continuing Operations for 15 consecutive years, with 6547351.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Income from Continuing Operations rose 4493.02% year-over-year to 6547351.0, compared with a TTM value of 333034.0 through Sep 2025, up 94.2%, and an annual FY2024 reading of 9821891.0, down 121.22% over the prior year.
  • Income from Continuing Operations was 6547351.0 for Q3 2025 at Sanara MedTech, up from 1822916.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 6547351.0 in Q3 2025 and bottomed at 4208281.0 in Q4 2022.
  • Average Income from Continuing Operations over 5 years is 1435858.58, with a median of 1799043.0 recorded in 2024.
  • The sharpest move saw Income from Continuing Operations crashed 534.05% in 2024, then soared 4493.02% in 2025.
  • Year by year, Income from Continuing Operations stood at 3412405.0 in 2021, then fell by 23.32% to 4208281.0 in 2022, then surged by 93.76% to 262444.0 in 2023, then plummeted by 534.05% to 1664020.0 in 2024, then soared by 493.47% to 6547351.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for SMTI at 6547351.0 in Q3 2025, 1822916.0 in Q2 2025, and 3393449.0 in Q1 2025.